Advate TM
Listen to the Pronunciation:
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: octocog alfa, inert substance
Brand name
(ARTG)
: ADVATE octocog alfa (rch) 4000 IU powder for injection vial with diluent vialConsumer Medicine Information (CMI)
Read the CMI leaflet for facts you need to know before, during and after taking your medicine.
Listen to the audio transcription of the CMI leaflet.
For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).
What this medicine is used for
(ARTG)
ADVATE is indicated for use in haemophilia A for prevention and control of haemorrhagic episodes. Patients with haemophilia A may be treated with ADVATE as perioperative management. ADVATE is not indicated in Von Willebrand's disease.
How to use this medicine
(ARTG)
This medicine is a pack that contains more than one component.
Component :
- Injection, powder for
- Intravenous
- white to off-white lyophilised powder
Component :
- Diluent, not applicable
- Intravenous
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Shelf lifetime is 2 Years.
Do I need a prescription ?
(ARTG)
We are unable to tell you if you need a prescription for these medicines. You can ask your pharmacist. This medicine is Not Scheduled.
- 1 vial with advate (octocog alfa (rch)) 4000 IU powder and 1 vial of diluent (WFI) with a drug delivery system (Baxject II or Baxject III) pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient octocog alfa
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: ADVATE octocog alfa (rch) 1500 IU powder for injection vial with diluent vialConsumer Medicine Information (CMI)
Read the CMI leaflet for facts you need to know before, during and after taking your medicine.
Listen to the audio transcription of the CMI leaflet.
For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).
What this medicine is used for
(ARTG)
Advate is indicated for use in haemophilia A for prevention and control of haemorrhagic episodes. Patients with haemophilia A may be treated with Advate as perioperative management. Advate is not indicated in von Willebrand's disease.
How to use this medicine
(ARTG)
This medicine is a pack that contains more than one component.
Component :
- Injection, powder for
- Intravenous
- white to off-white lyophilised powder
Component :
- Diluent, not applicable
- Intravenous
- Clear colourless liquid with no particulate matter
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Freeze
- Refrigerate
- Shelf lifetime is 2 Years.
Do I need a prescription ?
(ARTG)
We are unable to tell you if you need a prescription for these medicines. You can ask your pharmacist. This medicine is Not Scheduled.
- 1 vial with advate (octocog alfa (rch)) 1500 IU powder and 1 vial of diluent (WFI) with a drug delivery system (Baxject II or Baxject III) pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient octocog alfa
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: ADVATE octocog alfa (rch) 250 IU powder for injection vial with diluent vialConsumer Medicine Information (CMI)
Read the CMI leaflet for facts you need to know before, during and after taking your medicine.
Listen to the audio transcription of the CMI leaflet.
For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).
What this medicine is used for
(ARTG)
Advate is indicated for use in haemophilia A for prevention and control of harmorrhagic episodes. Patients with haemophilia A may be treated with Advate as perioperative management. Advate is not indicated in von Willebrand's disease.
How to use this medicine
(ARTG)
This medicine is a pack that contains more than one component.
Component :
- Injection, powder for
- Intravenous
- white to off-white lyophilised powder
Component :
- Diluent, not applicable
- Intravenous
- clear colourless liquid with no particulate matter
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Freeze
- Refrigerate
- Shelf lifetime is 2 Years.
Do I need a prescription ?
(ARTG)
We are unable to tell you if you need a prescription for these medicines. You can ask your pharmacist. This medicine is Not Scheduled.
- 1 vial with advate (octocog alfa (rch)) 250 IU powder and 1 vial of diluent (WFI) with a drug delivery system (Baxject II or Baxject III) pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient octocog alfa
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: ADVATE octocog alfa (rch) 500 IU powder for injection vial with diluent vialConsumer Medicine Information (CMI)
Read the CMI leaflet for facts you need to know before, during and after taking your medicine.
Listen to the audio transcription of the CMI leaflet.
For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).
What this medicine is used for
(ARTG)
Advate is indicated or use in haemophilia A for prevention and control of haermorrhagic episodes. Patients with haemophilia A may be treated with Advate as perioperative management. Advate is not indicated in von Wllebrand's disease
How to use this medicine
(ARTG)
This medicine is a pack that contains more than one component.
Component :
- Injection, powder for
- Intravenous
- white to off-white lyophilised powder
Component :
- Diluent, not applicable
- Intravenous
- clear colourless liquid with no particulate matter
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Freeze
- Refrigerate
- Shelf lifetime is 2 Years.
Do I need a prescription ?
(ARTG)
We are unable to tell you if you need a prescription for these medicines. You can ask your pharmacist. This medicine is Not Scheduled.
- 1 vial with advate (octocog alfa (rch)) 500 IU powder and 1 vial of diluent (WFI) with a drug delivery system (Baxject II or Baxject III)) pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient octocog alfa
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: ADVATE octocog alfa (rch) 1000 IU powder for injection vial with diluent vialConsumer Medicine Information (CMI)
Read the CMI leaflet for facts you need to know before, during and after taking your medicine.
Listen to the audio transcription of the CMI leaflet.
For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).
What this medicine is used for
(ARTG)
Advate is indicated for use in haemophilia A for prevention and control of haemorrhagic episodes. Patients with haemophilia A may be treated with Advate as perioperative management. Advate is not indicated in von Willebrand's disease.
How to use this medicine
(ARTG)
This medicine is a pack that contains more than one component.
Component :
- Diluent, not applicable
- Intravenous
- Clear colourless liquid with no particulate matter
Component :
- Injection, powder for
- Intravenous
- white to off-white lyophilised powder
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Freeze
- Refrigerate
- Shelf lifetime is 2 Years.
Do I need a prescription ?
(ARTG)
We are unable to tell you if you need a prescription for these medicines. You can ask your pharmacist. This medicine is Not Scheduled.
- 1 vial with advate (octocog alfa (rch)) 1000 IU powder and 1 vial of diluent (WFI) with a drug delivery system (Baxject II or Baxject III) pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient octocog alfa
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: ADVATE octocog alfa (rch) 2000 IU powder for injection vial with diluent vialConsumer Medicine Information (CMI)
Read the CMI leaflet for facts you need to know before, during and after taking your medicine.
Listen to the audio transcription of the CMI leaflet.
For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).
What this medicine is used for
(ARTG)
Advate is indicated for use in haemophilia A for prevention and control of haemorrhagic episodes. Patients with haemophilia A may be treated with Advate as perioperative management. Advate is not indicated in von Willebrand's disease.
How to use this medicine
(ARTG)
This medicine is a pack that contains more than one component.
Component :
- Injection, diluent for
- Intravenous
- Clear colourless liquid with no particulate matter
Component :
- Injection, powder for
- Intravenous
- white to off-white lyophilised powder
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Freeze
- Refrigerate
- Shelf lifetime is 2 Years.
Do I need a prescription ?
(ARTG)
We are unable to tell you if you need a prescription for these medicines. You can ask your pharmacist. This medicine is Not Scheduled.
- 1 vial with advate (octocog alfa (rch)) 2000 IU powder and 1 vial of diluent (WFI) with a drug delivery system (Baxject II or Baxject III) pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient octocog alfa
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: ADVATE octocog alfa (rch) 3000 IU powder for injection vial with diluent vialConsumer Medicine Information (CMI)
Read the CMI leaflet for facts you need to know before, during and after taking your medicine.
Listen to the audio transcription of the CMI leaflet.
For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).
What this medicine is used for
(ARTG)
ADVATE is indicated for use in haemophilia A for prevention and control of haemorrhagic episodes. Patients with haemophilia A may be treated with ADVATE as perioperative management. ADVATE is not indicated in von Willebrands disease.
How to use this medicine
(ARTG)
This medicine is a pack that contains more than one component.
Component :
- Injection, diluent for
- Intravenous
- Clear colourless liquid with no particulate matter
Component :
- Injection, powder for
- Intravenous
- white to off-white lyophilised powder
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Freeze
- Refrigerate
- Shelf lifetime is 2 Years.
Do I need a prescription ?
(ARTG)
We are unable to tell you if you need a prescription for these medicines. You can ask your pharmacist. This medicine is Not Scheduled.
- 1 vial with advate (octocog alfa (rch)) 3000 IU powder and 1 vial of diluent (WFI) with a drug delivery system (Baxject II or Baxject III) pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient octocog alfa
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: ADVATE octocog alfa (rch) 500 IU powder for injection vial with diluent vialConsumer Medicine Information (CMI)
Read the CMI leaflet for facts you need to know before, during and after taking your medicine.
Listen to the audio transcription of the CMI leaflet.
For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).
What this medicine is used for
(ARTG)
Advate is indicated or use in haemophilia A for prevention and control of haermorrhagic episodes. Patients with haemophilia A may be treated with Advate as perioperative management. Advate is not indicated in von Wllebrand's disease
How to use this medicine
(ARTG)
This medicine is a pack that contains more than one component.
Component :
- Injection, powder for
- Intravenous
- white to off-white lyophilised powder
Component :
- Diluent, not applicable
- Intravenous
- clear colourless liquid with no particulate matter
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Freeze
- Refrigerate
- Shelf lifetime is 2 Years.
Do I need a prescription ?
(ARTG)
We are unable to tell you if you need a prescription for these medicines. You can ask your pharmacist. This medicine is Not Scheduled.
- 1 vial with advate (octocog alfa (rch)) 500 IU powder and 1 vial of diluent (WFI) with a drug delivery system (Baxject II or Baxject III)) pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient octocog alfa
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: ADVATE octocog alfa (rch) 250 IU powder for injection vial with diluent vialConsumer Medicine Information (CMI)
Read the CMI leaflet for facts you need to know before, during and after taking your medicine.
Listen to the audio transcription of the CMI leaflet.
For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).
What this medicine is used for
(ARTG)
Advate is indicated for use in haemophilia A for prevention and control of harmorrhagic episodes. Patients with haemophilia A may be treated with Advate as perioperative management. Advate is not indicated in von Willebrand's disease.
How to use this medicine
(ARTG)
This medicine is a pack that contains more than one component.
Component :
- Injection, powder for
- Intravenous
- white to off-white lyophilised powder
Component :
- Diluent, not applicable
- Intravenous
- clear colourless liquid with no particulate matter
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Freeze
- Refrigerate
- Shelf lifetime is 2 Years.
Do I need a prescription ?
(ARTG)
We are unable to tell you if you need a prescription for these medicines. You can ask your pharmacist. This medicine is Not Scheduled.
- 1 vial with advate (octocog alfa (rch)) 250 IU powder and 1 vial of diluent (WFI) with a drug delivery system (Baxject II or Baxject III) pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient octocog alfa
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: ADVATE octocog alfa (rch) 1000 IU powder for injection vial with diluent vialConsumer Medicine Information (CMI)
Read the CMI leaflet for facts you need to know before, during and after taking your medicine.
Listen to the audio transcription of the CMI leaflet.
For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).
What this medicine is used for
(ARTG)
Advate is indicated for use in haemophilia A for prevention and control of haemorrhagic episodes. Patients with haemophilia A may be treated with Advate as perioperative management. Advate is not indicated in von Willebrand's disease.
How to use this medicine
(ARTG)
This medicine is a pack that contains more than one component.
Component :
- Diluent, not applicable
- Intravenous
- Clear colourless liquid with no particulate matter
Component :
- Injection, powder for
- Intravenous
- white to off-white lyophilised powder
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Freeze
- Refrigerate
- Shelf lifetime is 2 Years.
Do I need a prescription ?
(ARTG)
We are unable to tell you if you need a prescription for these medicines. You can ask your pharmacist. This medicine is Not Scheduled.
- 1 vial with advate (octocog alfa (rch)) 1000 IU powder and 1 vial of diluent (WFI) with a drug delivery system (Baxject II or Baxject III) pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient octocog alfa
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: ADVATE octocog alfa (rch) 1500 IU powder for injection vial with diluent vialConsumer Medicine Information (CMI)
Read the CMI leaflet for facts you need to know before, during and after taking your medicine.
Listen to the audio transcription of the CMI leaflet.
For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).
What this medicine is used for
(ARTG)
Advate is indicated for use in haemophilia A for prevention and control of haemorrhagic episodes. Patients with haemophilia A may be treated with Advate as perioperative management. Advate is not indicated in von Willebrand's disease.
How to use this medicine
(ARTG)
This medicine is a pack that contains more than one component.
Component :
- Injection, powder for
- Intravenous
- white to off-white lyophilised powder
Component :
- Diluent, not applicable
- Intravenous
- Clear colourless liquid with no particulate matter
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Freeze
- Refrigerate
- Shelf lifetime is 2 Years.
Do I need a prescription ?
(ARTG)
We are unable to tell you if you need a prescription for these medicines. You can ask your pharmacist. This medicine is Not Scheduled.
- 1 vial with advate (octocog alfa (rch)) 1500 IU powder and 1 vial of diluent (WFI) with a drug delivery system (Baxject II or Baxject III) pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient octocog alfa
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems